Currently, the project consists of both an ensemble component and a bayesian model component. Mostly the same expirements are run on both, but they produce very different results. The ensemble shows very good accuracy (a marked improvement over a single model) as well as promise with regards to uncertainty quantitifcation (although performance compared to a single model still needs to be evaluated). On the other hand, while the bayesian model does seem to do well with uncertainty quantification (from a monotonicity perspective), it struggles majorly with the actual predictions, and has a pitiful overall accuracy. This, in addition to the additional work required to get the ensemble in a useable state, means that the overall value of the bayesian analysis is, in my opinion, rather limited.
In contrast, ensemble methods have a couple of avenues of research still left to investigate, and show overall more promise as a pos-hoc method and as something that is very easy to implement into a pipeline. For these reasons, I think in a project focusing on clinical use, it makes sense to focus on the ensemble, and evaluate how well that method improves accuracy and uncertainty quantification compared to a single model.
If removing the bayesian ends up being the route that we actually want to do, the following lineup for the final paper makes the most sense to me
I think this is a pretty solid lineup, but I'll continue to work on it.